ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,662Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 2094

$1.48M Total Retail Price of All Prescriptions

Rank: 26 out of 2094

509 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 509 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

2% of this provider’s 509 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

3% of this provider’s 12,183 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 702 476 1 2
METFORMIN HCL 702 412 1 8
DIVALPROEX SODIUM 699 409 3 69
LEVOTHYROXINE SODIUM 641 418 4 3
SIMVASTATIN 625 352 5 1
BENZTROPINE MESYLATE 466 265 R 6 157
RISPERIDONE 460 262 7 56
LISINOPRIL 429 229 8 7
FUROSEMIDE 398 324 9 6
OMEPRAZOLE 364 251 10 4
HALOPERIDOL 353 166 11 196
METOPROLOL TARTRATE 346 225 12 10
QUETIAPINE FUMARATE 308 237 13 71
LANTUS SOLOSTAR 261 75 14 76
ALENDRONATE SODIUM 253 225 15 30
CLOZAPINE 251 87 16 212
TAMSULOSIN HCL 212 109 17 29
LEVETIRACETAM 195 105 18 78
JANUVIA 187 125 19 35
NOVOLOG FLEXPEN 181 67 20 142
MIRTAZAPINE 168 121 21 43
DIOVAN 162 92 22 13
GLIPIZIDE 157 113 23 82
GABAPENTIN 154 107 24 23
ABILIFY 144 64 25 165
FAMOTIDINE 142 100 26 34
HYDROCHLOROTHIAZIDE 137 111 27 12
CLOPIDOGREL 137 112 27 22
DONEPEZIL HCL 133 103 29 20
VALPROIC ACID 131 65 30 221
SINGULAIR 130 108 31 64
METOPROLOL SUCCINATE 123 109 32 9
WARFARIN SODIUM 122 83 33 11
OLANZAPINE 121 77 34 113
OXYBUTYNIN CHLORIDE ER 121 94 34 138
OXCARBAZEPINE 113 44 36 257
CARVEDILOL 113 110 36 19
ATORVASTATIN CALCIUM 112 70 38 5
PEN NEEDLE 110 44 39 136
PLAVIX 109 90 40 38
SEROQUEL 107 95 41 172
ATENOLOL 105 91 42 21
LANTUS 103 66 43 66
LAMOTRIGINE 99 22 44 177
HALOPERIDOL DECANOATE 98 45 45 430
NAMENDA 97 97 46 32
LOSARTAN POTASSIUM 95 82 47 17
NEXIUM 94 70 48 16
CRESTOR 92 76 49 15
ADVAIR DISKUS 90 60 50 36
ENALAPRIL MALEATE 89 70 51 25
NOVOLOG 85 53 52 116
FLUPHENAZINE HCL 80 23 53 446
RAMIPRIL 79 72 54 48
ENULOSE 75 59 55 303
AZITHROMYCIN 75 57 55 27
CLONIDINE HCL 75 60 55 62
LEVOFLOXACIN 75 61 55 70
ESCITALOPRAM OXALATE 73 63 59 46
LITHIUM CARBONATE 72 18 60 412
FENOFIBRATE 72 21 60 104
SODIUM CHLORIDE 71 48 62 254
ALBUTEROL SULFATE 71 69 62 90
LIPITOR 70 37 64 39
TRAZODONE HCL 69 51 65 72
TRAMADOL HCL 69 40 65 33
GLIMEPIRIDE 69 66 65 31
KLOR-CON M20 68 30 68 106
SERTRALINE HCL 68 52 68 26
ACTOS 66 35 70 112
RISPERDAL CONSTA 64 19 71 469
PERMETHRIN 64 37 71 361
MELOXICAM 63 58 73 49
SPIRONOLACTONE 62 43 74 93
DIGOXIN 62 62 74 51
GLYBURIDE 60 28 R 76 95
DETROL LA 59 44 77 233
CLOTRIMAZOLE-BETAMETHASONE 58 48 78 91
AMOX TR-POTASSIUM CLAVULANATE 57 41 79 107
IBUPROFEN 56 51 80 73
PROAIR HFA 56 35 80 45
GLYBURIDE-METFORMIN HCL 53 41 R 82 94
CELEBREX 51 49 83 74
LIDODERM 51 51 83 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 23, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.